Press release
Chronic Pain Market [2025-2032] - Exclusive Report Featuring In-Depth Analysis and Leading Key Players Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC
Chronic Pain Market
Get Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/4767
➤ Analyst Opinion
● Rising prescription rates for novel non-opioid analgesics and biologics have notably contributed to market growth. For example, in 2024, sales of targeted therapies increased by 15%, evidencing heightened adoption due to safety and efficacy profiles compared to traditional opioids.
● The demand-side indicators, such as increased healthcare expenditure in North America and Europe, with respective rises of 6.8% and 5.9% in chronic pain therapeutic spending in 2024, affirm sustained market expansion. These figures affirm the correlation between healthcare investment and market revenue uplift in the chronic pain sector.
● Supply-side dynamics, including augmentation of manufacturing capacities for sustained-release formulations and innovative analgesic devices, showed a 12% expansion in production volumes in 2025. Companies scaling production to meet rising global volume requirements indicate a maturation of supply chains supporting market share growth.
● Micro-market shifts towards personalized pain management and telehealth integration have driven greater patient adherence and monitoring. Studies from 2024 suggest that telemedicine-supported chronic pain management reduced hospital readmissions by 18%, marking a key market trend deeply influencing market analysis and future growth strategies.
➤Market Taxonomy and Regional coverage of Report
● Comprehensive Taxonomy of the Report:
» By Pain Type: Neuropathic Pain, Musculoskeletal Pain, Inflammatory Pain, Postoperative Pain, and Others.
» By Treatment Type: Pharmacological, Medical Devices, Complementary and Alternative Therapies, and Others.
» By Application: Arthritis, Cancer Pain, Back Pain, Fibromyalgia, and Others.
● Regional and Country Analysis:
» North America: U.S. and Canada
» Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
» Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
» Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
» Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/4767
➤ Leading Companies of the Market
● Pfizer Inc.
● Johnson & Johnson
● GlaxoSmithKline PLC
● Bayer AG
● Novartis AG
● Endo Pharmaceuticals
● Bristol-Myers Squibb
● Eli Lilly and Company
● Teva Pharmaceutical Industries Ltd.
● Reckitt Benckiser Group plc
● Medtronic plc
● AstraZeneca PLC
● Becton, Dickinson and Company
● AbbVie Inc.
● Horizon Therapeutics
● Mallinckrodt Pharmaceuticals
● Zynerba Pharmaceuticals
● Neurocrine Biosciences
● Sorrento Therapeutics
● Cypress Pharmaceutical
In recent years, Pfizer Inc. has focused on strategic partnerships to expand its chronic pain portfolio, leading to a 20% revenue growth in 2024 through co-development deals of novel analgesics. Johnson & Johnson implemented aggressive in-licensing strategies for innovative neuromodulation devices, resulting in expanded market share within the medical devices segment. Additionally, Bayer AG successfully launched key biologic therapies in emerging markets, accelerating its market penetration and above-average revenue performance in Asia Pacific.
➤Key Growth Drivers Fuelling Market Expansion
The chronic pain market growth in 2025 and beyond is primarily driven by an aging global population prone to chronic musculoskeletal and neuropathic conditions, fueling consistent demand for advanced pain management therapies. Increasing regulatory approvals for non-opioid analgesics and growth in over-the-counter analgesic adoption support wider treatment access and represent pivotal market drivers backed by 14% CAGR in product launches reported in 2024. Furthermore, digital transformation initiatives incorporating telehealth and remote patient monitoring platforms enhance clinical outcomes and patient engagement, reinforcing chronic pain market revenue streams. Rising healthcare expenditure across developed and developing regions markedly supports infrastructure investment and increases market scope, with Asia Pacific exhibiting a projected 9.3% CAGR in market growth owing to healthcare reforms and growing middle-class access to care.
➤ Key Reasons for Buying the Chronic Pain Report
✦ Comprehensive analysis of the changing competitive landscape
✦ Assists in decision-making processes for the businesses along with detailed strategic planning methodologies
✦ The report offers forecast data and an assessment of the Chronic Pain Market
✦ Helps in understanding the key product segments and their estimated growth rate
✦ In-depth analysis of market drivers, restraints, trends, and opportunities
✦ Comprehensive regional analysis of the Chronic Pain Market
✦ Extensive profiling of the key stakeholders of the business sphere
✦ Detailed analysis of the factors influencing the growth of the Chronic Pain Market
➤ Emerging Trends and Market Shift
Recent trends in the chronic pain market include accelerated adoption of minimally invasive neuromodulation therapies and personalized medicine approaches utilizing genetic profiling for treatment customization. Digital health interventions have seen greater integration, reflecting a shift from traditional episodic treatment models to continuous care management using mobile applications and AI algorithms to predict pain flare-ups. Additionally, there is a discernible migration towards value-based care models emphasizing treatment efficacy and cost containment, which strongly influences chronic pain market dynamics and strategic direction.
➤ High-Impact Market Opportunities by Segment and Region
Among treatment types, pharmacological segments focusing on non-opioid analgesics offer significant expansion potential by addressing regulatory concerns and diversifying therapy portfolios, as evidenced by a 16% increase in pharmaceutical R&D investment in 2025. Neuropathic pain applications are expected to yield considerable market revenue growth due to intensified awareness campaigns and improved diagnostic tools enhancing early intervention rates. The medical devices segment, particularly wearable neurostimulation devices, is positioned for rapid uptake given its non-invasive nature and rising patient preference, with regional data from North America showing a 22% surge in device adoption in 2024. Regionally, the Asia Pacific market reveals vast opportunities due to growing healthcare infrastructure and increasing prevalence of chronic diseases; countries like China and India are projected to surpass a CAGR of 9% between 2025 and 2032, becoming key revenue contributors and reshaping the market share landscape.
To Purchase This Premium Report, Click Here (Discount of Up to 25%): https://www.coherentmarketinsights.com/insight/buy-now/4767
❓ Frequently Asked Questions
1. Who are the dominant players in the Chronic Pain market?
Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC, Bayer AG, and Novartis AG are among the leading market players, dominating through innovation, strategic partnerships, and geographic expansion.
2. What will be the size of the Chronic Pain market in the coming years?
The market size for chronic pain is forecasted to grow from USD 77.30 billion in 2025 to USD 125.84 billion by 2032, reflecting a CAGR of 7.2%, driven by rising patient demand and therapeutic advancements.
3. Which end users industry has the largest growth opportunity?
The pharmaceutical segment, particularly non-opioid analgesics and biologics, represents the largest growth opportunity, supported by increasing regulatory approvals and shifting treatment paradigms in pain management.
4. What is the nature of the competitive landscape and challenges in the Chronic Pain market?
The competitive landscape is defined by intensive R&D investments, aggressive licensing strategies, and portfolio diversification. Market challenges include regulatory complexities, evolving reimbursement policies, and demand for safer non-addictive therapies.
5. What go-to-market strategies are commonly adopted in the Chronic Pain market?
Leading companies leverage collaborations, product innovation, and expansion into emerging markets to enhance market penetration, along with digital marketing strategies that support patient education and physician engagement.
Author of this Marketing PR:
Ravina Pandya, PR Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: + 442039578553
AUS: + 61879247805
INDIA: +91-848-285-0837
About CMI:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Pain Market [2025-2032] - Exclusive Report Featuring In-Depth Analysis and Leading Key Players Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC here
News-ID: 4126382 • Views: …
More Releases from Coherent Market Insights Pvt. Ltd.
Phase I Environmental Site Assessment Market Share, Revenue, Price, Growth Rate, …
The Phase I Environmental Site Assessment Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Phase I Environmental Site Assessment Market dynamics. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand…
Medical Aesthetics Market Share, Revenue, Price, Growth Rate, and Ranking Analys …
The Medical Aesthetics Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Medical Aesthetics Market dynamics. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand a valuable resource. Also, the report…
Life Plan Communities Market Projections 2025-2032: Key Trends, Opportunities, a …
Worldwide Market Reports has added a new research study on the Global "Life Plan Communities Market" 2025 by Size, Growth, Trends, and Dynamics, Forecast to 2032 which is a result of an extensive examination of the market patterns. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion…
Baking Ingredients Market Trends, Investment Opportunities, and Growth Analysis …
The Baking Ingredients Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Baking Ingredients Market dynamics. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand a valuable resource. Also, the report…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
